Bombesin-like receptor 3: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 05:12, 17 March 2025
Bombesin-like receptor 3 (BRS-3) is a protein that in humans is encoded by the BRS3 gene. BRS-3 is a member of the bombesin family of receptors, which also includes gastrin-releasing peptide receptor and neuromedin B receptor.
Function[edit]
BRS-3 is a G protein-coupled receptor that is not known to be naturally activated by any endogenous ligand. However, it has been shown to bind synthetic ligands such as bombesin and gastrin-releasing peptide. The function of BRS-3 is not well understood, but it is thought to play a role in energy homeostasis and body weight regulation.
Clinical significance[edit]
Mutations in the BRS3 gene have been associated with obesity in humans and mice. In addition, BRS-3 has been implicated in the regulation of insulin secretion and glucose metabolism, suggesting a potential role in the development of type 2 diabetes.
See also[edit]
References[edit]
<references />

This article is a Human chromosome 8 gene stub. You can help WikiMD by expanding it!
